Loading...
FAQs
A-
A+

Fonts Size

Change Color

Hit enter to search or ESC to close
A-
A+

Fonts Size

Change Color

Alert:

Healthcare facilities are required to complete the Training Programme on Abu Dhabi Healthcare Guidelines for Health Media & Advertising System as mentioned in circular number 26/2023, for more information Click Here

DOH urges all healthcare and pharmaceutical facilities & Health professional to Adhere to the circular number(63\2021) by updating the details of the mobile number & e-mail address in order to receive all circulars & letters issued by DOH, for more information Click Here

Abu Dhabi: Your Gate to the MENA Region’s Biopharmaceutical Industry

Abu Dhabi, the capital of the United Arab Emirates, is the leading healthcare destination in the MENA region with key unique characteristics that contribute to the Emirate’s prominence as a hub for healthcare, life sciences and innovation.

  • Advanced healthcare infrastructure
  • Agile and resilient ecosystem
  • Consistently ranked as the safest city in the world
  • Home to renowned global healthcare facilities and bodies
  • Supportive programs for innovation and entrepreneurship
  • Investor-friendly infrastructure supported by visionary leadership

BIO 2023 Abu Dhabi in BIO International Convention 2023

Set to participate at BIO International Convention 2023 from 6 to 8 June under the theme “Choose Abu Dhabi”, the Abu Dhabi Pavilion will host a wide group representing the Emirate’s diverse ecosystem to showcase the Emirate's remarkable advancements and dynamic growth in the biotechnology industry. Expect engaging discussions, invaluable exchanges of insights and expertise, and exploration of diverse investment opportunities and collaborations to take center stage. Abu Dhabi's presence at this convention promises to fuel innovation and propel partnerships that will shape a brighter future for all.


Abu Dhabi at BIO International Convention 2023

The annual BIO International Convention is taking place from 5-8 June 2023 in Boston. For the second year in a row, Abu Dhabi is set to participate. Under the theme “Choose Abu Dhabi”, the Abu Dhabi Pavilion will host a wide group representing the Emirate’s diverse ecosystem and showcasing the Emirate's remarkable advancements and dynamic growth in the biotechnology industry. Expect engaging discussions, invaluable exchanges of insights and expertise, as well as the exploration of diverse investment opportunities and collaborations to take center stage. Abu Dhabi's presence at this convention promises to fuel innovation and propel partnerships that will shape a healthier future for all.

To learn more about Abu Dhabi’s journey to help future-proof global public health, visit us at our booth #2649. We look forward to seeing you there!




Our Partners

Representing Abu Dhabi at BIO 2023

During BIO 2023, nine key entities representing Abu Dhabi’s health ecosystem partners will be at the booth, including The Department of Health – Abu Dhabi, which will lead the delegation, joined by the Abu Dhabi Investment Office (ADIO), Etihad Cargo, KEZAD Group, M42, G42, Mubadala Health, Sheikh Shakhbout Medical City (SSMC), Pure Health, and Daman, each of whom bring unique expertise and resources. Together, they represent Abu Dhabi's commitment to innovation, knowledge exchange, and international collaboration. This diverse array of stakeholders from various sectors embodies the region's dedication to driving transformative change in the world of life sciences.





News

The Department of Health – Abu Dhabi and Eli Lilly Suisse S.A sign Declaration of Collaboration to support clinical research and healthcare innovation

DoH and MSD GCC expand partnership during BIO International Convention 2023 to advance research in Oncology

Why Abu Dhabi

Where you can turn opportunities into innovation in healthcare



Abu Dhabi offers a multitude of potential opportunities for collaboration in the field of life sciences and healthcare. With a thriving ecosystem of health-tech start-ups, innovators, and researchers, the appetite to elevate efforts related research and clinical trials is larger than ever. The vibrant life science landscape in Abu Dhabi is a perfect fit for investors looking to leverage the Emirate’s advanced infrastructure and capitalise on its potential. By engaging with key healthcare players, industry bodies, and government entities, partnerships can be fostered to leverage expertise and resources for mutual growth. Seeking opportunities to connect with senior leadership in Abu Dhabi's healthcare sector further facilitates support and relationship-building for collaborative initiatives. Together, these opportunities create a conducive environment for advancing scientific knowledge, driving innovation, and making significant contributions to the global life science community.

  • Abu Dhabi boasts the world’s largest genomics program, having collected and sequenced over 430,000 genome samples. 
  • In 2022 alone, we witnessed a staggering 484% increase in the number of clinical trials conducted here. 
  • Clinical trial approvals are processed and completed within a mere 28 days, providing researchers and entrepreneurs with an unrivalled advantage in bringing their life-changing therapies to market swiftly and efficiently.
  • In 2022, our city also experienced an incredible 40% increase in the number of incubated start-ups and we welcomed 86 new companies into our ecosystem.

Find out more about Healthcare Life-Science in Abu Dhabi 2023 Download the Brochure

For Investment in Abu DHabi's healthcare sector contact us now: CPIR@doh.gov.ae

Investment Opportunities in Abu DHabi's Healthcare Sector

Find out more

Abu Dhabi is home to world-class MedTech solutions

Abu Dhabi’s focus on expanding its healthcare system, adopting innovative technologies and forging partnerships
with leading international hospitals has led to a flourishing MedTech sector

Laboratory technology

The National Reference Laboratory offers approx. 4,700 specialised medical diagnostic tests to local and regional healthcare providers In June 2020, G42 announced that the development of a new population scale technology is being incorporated into the UAE’s national testing strategy and is expected to scale testing to hundreds of thousands of samples daily

Electronic medical records

Malaffi is the region’s first Health Information Exchange platform that securely connects all public and private healthcare providers in Abu Dhabi. After just one year, Malaffi is recognised as one of the fastest HIE implementations globally, connecting 600 healthcare facilities, providing access to 26k+ users and 107m clinical records for 4 million patients.

3D printing

The UAE is embracing the power of 3D printing as it is part of its national healthcare strategy

NYU Abu Dhabi started collaborating with Mubadala Healthcare to create 3D printed N-95 masks that are more environmentally friendly while still providing the same level of protection against COVID-19 and other diseases

Internet of Medical Things (IoMT)

Abu Dhabi has recognised IoMT as the technology to improve the management of chronic diseases, which are prevalent in the UAE It has also demonstrated the ability to use IoTM during the pandemic as remote monitoring devices have helped monitor patients in a non-hospital setting and health authorities have used smart wristbands to track patients as they self-quarantine at home

Telemedicine


The Abu Dhabi Telemedicine Centre offers consultations over the phone, in both Arabic and English, 24h/day and 7 days/week

Cleveland Clinic Abu Dhabi uses telehealth to care for patients in the UAE and connects them to the flagship hospital in Cleveland, Ohio

Medical devices and equipment

Cleveland Clinic Abu Dhabi and Sheikh Khalifa Medical City boast world-class medical devices and equipment, such as robotic-assisted surgery equipment The most common robotics-assisted procedures are cardiac, digestive diseases, urological, and gynaecological procedures. In 2020, the hospital performed the first robotic “whipple” procedures to treat pancreatic and duodenal tumours

Abu Dhabi is the GCC’s Hub for Biopharmaceuticals

Goals & Vision

Abu Dhabi vision 2030 sees the pharmaceutical industry as one of the main sub sectors to develop, considering its future growth prospects, export potential and mid- to long-term economic impact

The Abu Dhabi Government is focused on minimising its reliance on imported pharmaceuticals. The UAE is estimated to have imported around AED 14.9b of pharmaceutical products from the world market in 2018. Local manufacturing of pharmaceuticals is now a primary goal for the government, the Ministry of Health and legislating authorities

Market Trends

Universal healthcare has been rolled out, creating a myriad of opportunities for biopharmaceuticals to cater to the country’s growing population. The proliferation of non-communicable lifestyle diseases means that the country’s medical needs will continue to grow in the coming years

For Investment in Abu DHabi's healthcare sector contact us now: CPIR@doh.gov.ae

Investment Opportunities in Abu DHabi's Healthcare Sector

Find out more

Subscribe for updates

Thanks for Subscribing

Last updated: 23 Nov 2024

Mobile For an optimal experience please
rotate your device to portrait mode